DLL1 and neoplasm: Together, the data suggest that LNT treatments combined with DLL1 overexpression promote the tumor accumulation of CD8+ T cells and CD11b+Ly6G+ neutrophils, as well as the activation of CD8+ T cells in LAP0297 lung tumors.